171 related articles for article (PubMed ID: 34745961)
1. TFDP3 as E2F Unique Partner, Has Crucial Roles in Cancer Cells and Testis.
Huang J; Wang Y; Liu J; Chu M; Wang Y
Front Oncol; 2021; 11():742462. PubMed ID: 34745961
[TBL] [Abstract][Full Text] [Related]
2. Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F.
Qiao H; Di Stefano L; Tian C; Li YY; Yin YH; Qian XP; Pang XW; Li Y; McNutt MA; Helin K; Zhang Y; Chen WF
J Biol Chem; 2007 Jan; 282(1):454-66. PubMed ID: 17062573
[TBL] [Abstract][Full Text] [Related]
3. TFDP3 inhibits E2F1-induced, p53-mediated apoptosis.
Tian C; Lv D; Qiao H; Zhang J; Yin YH; Qian XP; Wang YP; Zhang Y; Chen WF
Biochem Biophys Res Commun; 2007 Sep; 361(1):20-5. PubMed ID: 17632080
[TBL] [Abstract][Full Text] [Related]
4. TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.
Ding LY; Chu M; Jiao YS; Hao Q; Xiao P; Li HH; Guo Q; Wang YD
PLoS One; 2018; 13(9):e0203833. PubMed ID: 30235236
[TBL] [Abstract][Full Text] [Related]
5. Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro.
Jiao Y; Ding L; Chu M; Wang T; Kang J; Zhao X; Li H; Chen X; Gao Z; Gao L; Wang Y
PLoS One; 2017; 12(8):e0182781. PubMed ID: 28797103
[TBL] [Abstract][Full Text] [Related]
6. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
[TBL] [Abstract][Full Text] [Related]
7. TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer.
Yin K; Liu Y; Chu M; Wang Y
PLoS One; 2017; 12(1):e0170573. PubMed ID: 28114432
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of the polypeptide antibody against human transcriptional factors TFDP1 and TFDP3].
Tian C; Li YY; Qiao H; Zhang Y; Chen WF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):875-7. PubMed ID: 18782520
[TBL] [Abstract][Full Text] [Related]
9. [Effects of TFDP3 on regulating the autophagy and apoptosis of LNCaP cells].
Ren LF; Ma YY; Yue QH; Su MQ; Hao XK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):347-9. PubMed ID: 22482402
[TBL] [Abstract][Full Text] [Related]
10. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription.
Cartwright P; Müller H; Wagener C; Holm K; Helin K
Oncogene; 1998 Aug; 17(5):611-23. PubMed ID: 9704927
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
Sun HX; Xu Y; Yang XR; Wang WM; Bai H; Shi RY; Nayar SK; Devbhandari RP; He YZ; Zhu QF; Sun YF; Hu B; Khan M; Anders RA; Fan J
Hepatology; 2013 Mar; 57(3):1088-97. PubMed ID: 23212661
[TBL] [Abstract][Full Text] [Related]
12. The ancient function of RB-E2F pathway: insights from its evolutionary history.
Cao L; Peng B; Yao L; Zhang X; Sun K; Yang X; Yu L
Biol Direct; 2010 Sep; 5():55. PubMed ID: 20849664
[TBL] [Abstract][Full Text] [Related]
13. E2F-4, a new member of the E2F transcription factor family, interacts with p107.
Ginsberg D; Vairo G; Chittenden T; Xiao ZX; Xu G; Wydner KL; DeCaprio JA; Lawrence JB; Livingston DM
Genes Dev; 1994 Nov; 8(22):2665-79. PubMed ID: 7958924
[TBL] [Abstract][Full Text] [Related]
14. Arabidopsis E2F1 binds a sequence present in the promoter of S-phase-regulated gene AtCDC6 and is a member of a multigene family with differential activities.
de Jager SM; Menges M; Bauer UM; Murra JA
Plant Mol Biol; 2001 Nov; 47(4):555-68. PubMed ID: 11669580
[TBL] [Abstract][Full Text] [Related]
15. Differential activities of E2F family members: unique functions in regulating transcription.
Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.
Kurayoshi K; Ozono E; Iwanaga R; Bradford AP; Komori H; Ohtani K
Biochem Biophys Res Commun; 2014 Jul; 450(1):240-6. PubMed ID: 24893334
[TBL] [Abstract][Full Text] [Related]
17. TFDP3 confers chemoresistance in minimal residual disease within childhood T-cell acute lymphoblastic leukemia.
Chu M; Yin K; Dong Y; Wang P; Xue Y; Zhou P; Wang Y; Wang Y
Oncotarget; 2017 Jan; 8(1):1405-1415. PubMed ID: 27902457
[TBL] [Abstract][Full Text] [Related]
18. The identification of E2F1-specific target genes.
Wells J; Graveel CR; Bartley SM; Madore SJ; Farnham PJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3890-5. PubMed ID: 11904439
[TBL] [Abstract][Full Text] [Related]
19. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
Rubin SM; Gall AL; Zheng N; Pavletich NP
Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
[TBL] [Abstract][Full Text] [Related]
20. Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression.
Lukas J; Petersen BO; Holm K; Bartek J; Helin K
Mol Cell Biol; 1996 Mar; 16(3):1047-57. PubMed ID: 8622649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
